Private Equity

Updated:

Majycc eSante Invest

Majycc eSante Invest is a Private Equity Firm. Founded in 2018, it is a venture capital firm based in Paris, France, seeking to invest in the health tech...

Majycc eSante Invest logo

Majycc eSante Invest

Majycc eSante Invest is a Private Equity Firm. Founded in 2018, it is a venture capital firm based in Paris, France, seeking to invest in the health tech sector across France and Europe.

General information

Firm type

Private Equity Firm

Year founded

2018

Location

Region

Europe

Country

France

City

Paris

Corporate office

Paris, France

Sector focus

Digital HealthHealthcare Services

Frequently asked questions

What investment stages does Majycc eSante Invest target?

The firm targets early-stage companies, specifically at the seed and start-up phases. These are typically pre-revenue or early-traction digital health ventures seeking initial institutional capital to fund clinical validation and regulatory certification. The cheque size is commensurate with French early-stage rounds in this sector, generally below €2 million per initial entry.

Which sectors and geographies does Majycc eSante Invest focus on?

Majycc eSante Invest is exclusively focused on digital health — software and technology products that operate within regulated healthcare environments, including telemedicine, clinical workflow tools, and patient-data platforms. Geographically, the firm concentrates on France as its home market, with additional activity in Belgium, Switzerland, and francophone North Africa where shared language and similar regulatory frameworks apply.

Does Majycc eSante Invest operate as a venture capital fund or a holding company?

Majycc eSante Invest operates as a private equity firm making direct equity investments into portfolio companies, rather than as a fund-of-funds or a corporate venture arm. Its structure is that of a specialist early-stage investor deploying proprietary capital or managed commitments into a single-sector digital health portfolio.

How does Majycc eSante Invest source its deal flow?

Given its narrow mandate in French and francophone digital health, the firm's deal flow likely originates through deep clinical and hospital-system networks, relationships with medical-technology incubators, and France's publicly supported e-health innovation programs. Sourcing is probably relationship-driven rather than auction-based, reflecting the small, specialized community of practice around digital health in the French ecosystem.

What makes Majycc eSante Invest structurally distinct from other European early-stage funds?

The firm's structural differentiator is its exclusive concentration on digital health — it does not diversify across other technology verticals, life sciences, or generalist consumer tech. Most European early-stage funds spread bets across digital, deeptech, and biotech to manage binary regulatory risk; Majycc eSante instead bets that deep domain expertise in a single regulated vertical will produce better sourcing and underwriting outcomes.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Paris Private Equity Firm profiles